Protein Kinase C Alpha and Tumorigenesis of the Endocrine Gland

Hormone Research in Paediatrics

Volumn 47, Issue 4-6, 1997, Pages 140-144

  Prévostel, Corinne ^a   Martin, Annick ^a   Alvaro, Véronique ^b   Jaffiol, Claude ^c   Joubert, Dominique ^a  

^a INSERM   (France)

^b FONDATION JEAN DAUSSET CEPH   (France)

^c LAPEYRONIE HOSPITAL   (France)

Author keywords

Allele specific oligonucleotide hybridization; Point mutation; Protein kinase Ca; Tumorigenesis

Indexed keywords

PROTEIN KINASE C;

CARCINOGENESIS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ENDOCRINE TUMOR; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; ENZYME SUBUNIT; HUMAN; HUMAN TISSUE; HYPOPHYSIS TUMOR; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; THYROID TUMOR;

ADENOMA; BASE SEQUENCE; CARCINOMA, PAPILLARY; DNA, NEOPLASM; HUMANS; PHOSPHORYLATION; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN KINASE C; SUBSTRATE SPECIFICITY; THYROID NEOPLASMS;

EID: 1842333960     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185457     Document Type: Article

References (25)

1. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C (review), Science 1992:258:607-614.
2. Ilug H, Sarrc TF: Protein kinase C isoenzymes: Divergence in signal transduction? Biochem J 1993:291:329-343.
3. Johannes FJ, Prestle J, Eis S, Oberhagemann P, Pfizenmaicr K: PKC'n is a novel, atypical member of the protein kinase C family, J Biol Chem 1994:269:6140-6148.
4. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y: Direct activation of calcium phospholipid-dependent protein kinase by tumor-promoting phorbol esters, J Biol Chem 1982:257:7847-7851.
5. Housey GM, Johnson MD, Hsiao WL, O'Brian CA, Murphy JP, Kirschmcier P, Weinstein IB: Overproduction of protein kinase C causes disordered growth control in rat fibroblasts, Cell 1988:52:343-354.
6. Cacace AM, Guadagno SN, Krauss RS, Fabbro D, Weinstein IB: The epsilon isoform of protein kinase C is an oncogene when overex-presscd in rat fibroblasts, Oncogene I993;8: 2095-2104.
7. Finkenzellcr G, Marme D, Hug H: Inducible overcxprcssion of human protein kinase Ca in NIH 3T3 fibroblasts results in growth abnor-malit ies, Cell Signal 1992:4:163-177.
8. Eldar H, Zisman Y, Ullrich A, Livneh E: Overexpression of protein kinase Ca-subtype in Swiss/3T3 fibroblasts causes loss of both high and low affinity receptor numbers for epider-mial growth factor, J Biol Chem 1990:265: 13290-13296.
9. Bomcr C, Ueffing M, Jaken S, Parker PJ, Weinstein IB: Two closely related isoforms of protein kinase C produce reciprocal efTects on the growth of rat fibroblasts, J Biol Chem 1995: 270:78-86.
10. Liu B, Maher RJ, Hannun YA, Porter AT, Honn KV: 12(S)-HETE enhancement of prostate tumor cell invasion: Selective role of PKCa, J Natl Cancer Inst 1994:86:1145-1151.
11. Mappeli E, Banfi P, Sala E, Sensi M, Supino R, Zunino F, Gambclta R: Effect of PKC inhibitors on invasivcness of human melanoma clones expressing different levels of PKC isoenzymes, lnt J Cancer 1994:57:281-286.
12. Ways DK, Kukoly CA, De Vcnte J, Hooker JL, Bryant WO, Posekany KJ, Fletcher DJ, Cook PP, Parker PJ: MCF-7 breast cancer cells transfected with protein kinase C-a exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype, J Clin Invest 1995:95:1906-1915.
13. Ahmad S, Glazer Rl: Expression of the antisense cDNA for Protein Kinase Ca attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells, Mol Pharmacol 1993: 43:858-862.
14. Yu G, Ahmad S, Aquino A, Fairchild CR, Tre-pel JB, Ohno S, Suzuki K, Tsuruo T, Cowan KH, Glazer RI: Transfection with protein kinase Ca confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotcin, Cancer Communications 1991;3:181-189.
15. Alvaro V, Livy L, Dubray C, Roche A, Peillon F, Querat B, Joubcrt D: Invasive human pituitary tumors express a point mutated a-protcin kinase C, J Clin Endocrinol Metab 1993:77: 1125-1129.
16. Prevostcl C, Alvaro V, De Boisvilliers F, Martin A, Jaffiol C, Joubert D: The natural protein kinase Cu mutant is present in human thyroid neoplasms, Oncogene 1995; 11:669-674.
17. Namba II, Gutman RA, Matsuo K, Alvarez A, Fagin JA: H-ras proto-oncogene mutations in human thyroid neoplasm, J Clin Endocrinol Metab 1990;71:223-229.
18. Hsiao W, Housey GM, Johnson MD, Weinstein IB: Cells that overproduce protein kinase C arc more susceptible to transformation by an activated H-ras oncogene, Mol Cell Biol 1989: 9:2641-2647.
19. Bonier C, Nichols Guadagno S, Fabbro D, Weinstein IB: Expression of four protein kinase C isoforms in rat fibroblasts, Distinct subcellu-lar distribution and regulation by calcium and phorbol esters, J Biol Chem 1992:267:12892-12899.
20. Bomer C, Nichols Guadano S, Hsiao W, Fabbro D, Barr M, Weinstein IB: Expression of four protein kinase C isoforms in rat fibroblasts, Differential alteration in ras-, sre-, and fos-transformed cells, J Biol Chem 1992:267: 12900-12910.
21. Alvaro V, Touraine PH, Raisman-Vozari R, Bai-Grenicr F, Birman P, Joubert-Bression D: Protein kinase C activity and expression in normal and adenomatous human pituitarics, Int J Cancer 1992;50:724-730.
22. Fagin JA: Genetic basis of endocrine Disease, Molecular defects in thyroid gland neoplasia, J Clin Endocrinol Metab 1992:75:1398-1400.
23. Parker PJ, Coussens L, Totty N, Rhee I., Young S, Chen E, Stabel S, Waterfield MD, Ullrich A: The complete primary structure of protein kinase C - the major phorbol ester receptor, Science 1986:233:853-858.
24. Kishimoto A, Mikawa K, Hashimoto K, Yasu-da I, Tanaka SI, Tominaga M, Kuroda T, Nishizuka Y: Limited proteoäysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain), J Biol Chem 1989; 254:4088-4092.
25. Junco M, Webster C, Crawford C, Bosca L, Parker PJ: 1994, Protein kinase C V3 domain mutants with differential sensitivities to m-cal-pain are not resistant to phorbol-ester-induced downregulation, Eur J Biochem 1994,223:259-263.